Monthly Archives: July 2016

Analysis of Crash Risk Under the Influence of Drugs

forensic toxicology working group members July 29, 2016 Forensic Toxicology

This article explains Analysis of Crash Risk Under the Influence of Drugs and the scientific, legal or practical evidence readers should understand.

Understanding Pharmacogenetic Variability

forensic toxicology working group members July 22, 2016 Forensic Toxicology

This article explains Understanding Pharmacogenetic Variability and the scientific, legal or practical evidence readers should understand.

Discussing the Different Variables of Addiction

forensic toxicology working group members July 19, 2016 Forensic Toxicology

This article explains Discussing the Different Variables of Addiction and the scientific, legal or practical evidence readers should understand.

DUI Misdemeanor vs Felony

forensic toxicology working group members July 15, 2016 Forensic Toxicology

This article explains DUI Misdemeanor vs Felony and the scientific, legal or practical evidence readers should understand.

Understanding Pharmacokinetic Variability

forensic toxicology working group members July 12, 2016 Forensic Toxicology

This article explains Understanding Pharmacokinetic Variability and the scientific, legal or practical evidence readers should understand.

Why Having a Toxicology Expert Witness will help Your Motor Vehicle Accident Case

forensic toxicology working group members July 5, 2016 Forensic Toxicology

This article explains Why Having a Toxicology Expert Witness will help Your Motor Vehicle Accident Case and the scientific, legal or practical evidence readers should understand.

Understanding Pharmacodynamic Variability

forensic toxicology working group members July 1, 2016 Forensic Toxicology

This article explains Understanding Pharmacodynamic Variability and the scientific, legal or practical evidence readers should understand.

Recent Blog Articles

October 22, 2026

Total and Unbound Drug Concentrations: What a Fasting Study Could Not Resolve

A laboratory can quantify total drug in plasma while struggling to quantify the much smaller unbound portion. That difference can determine whether a pharmacokinetic study answers its question. A result reported as not statistically significant does not resolve the question when the measurements are too limited to detect a meaningful…

Read Article: Total and Unbound Drug Concentrations: What a Fasting Study Could Not Resolve

October 21, 2026

Midazolam Sedation Models: Why a Medication Association Does Not Prove Antagonism

A medication can be associated with a different drug response because of the condition it was prescribed to treat. That possibility matters when interpreting a concentration-response model as evidence of a pharmacodynamic interaction. Franken and colleagues examined this problem in a study of midazolam sedation in terminally ill adults. Their…

Read Article: Midazolam Sedation Models: Why a Medication Association Does Not Prove Antagonism

October 21, 2026

CBD After Repeated Dosing: Why Detectability Does Not Establish a Washout Deadline

A cannabinoid detected after dosing stops is evidence of analytical persistence. It does not, by itself, establish an exact elimination half-life, the time of the last dose or a universal date when another person’s sample will test negative. A controlled study by Wolinsky and colleagues helps explain the distinction. Published…

Read Article: CBD After Repeated Dosing: Why Detectability Does Not Establish a Washout Deadline